The key to reducing healthcare associated infections

Carefusion helps their customers to measurably improve patient care by working in close partnership with hospitals to protect both operating teams and patients through the provision of clinically proven infection prevention products.

With innovative healthcare products and a worldwide support network, CareFusion is a global corporation serving the healthcare industry with some of the most widely recognized products and services.


Patient’s skin dwelling bacteria are the major source of infections associated with medical and surgical invasive procedures.  Normally ‘harmless’, these bacteria live in the top five cell layers of the skin1 and can enter the bloodstream whenever the integrity of the skin is breached, - for example in surgery.  
Whilst hand washing and appropriate environmental cleaning are essential to the prevention of cross-contamination and limiting the spread of MRSA, the patient and their skin should not be left out of the prevention equation.  Blood stream and surgical site infections remain a significant burden to the NHS, patients and their families.  The use of all appropriate, evidence based measures to prevent the avoidable infections is paramount.

ChloraPrep® is the ‘only licensed and evidence–based skin preparation system’ that meets the new Department of Health High Impact Intervention to prevent surgical site infection2 3
The 2% Chlorhexidine concentration is now proven in 39 outcome studies and recommended in 12 evidence-based guidelines.


ChloraPrep® is a medicinal product containing a solution of 2% chlorhexidine gluconate (w/v) in 70% isopropyl alcohol (v/v) and is a licensed, single use, sterile, ‘non-touch’ skin antisepsis system available in both clear and tint in a variety of sized applicators.  ChloraPrep® is applied with a gentle back and forth motion for 30 seconds and then allowed to air dry completely prior to invasive procedures.
CareFusion is committed to providing a safer environment for everyone.


1 Hendley JO, Ashe KM. Antimicrob Agents Chemother 1991; 35:627-31.
2 UK PL 31760/0001
3 Department of Health (2011) High Impact Intervention: Care Bundle to prevent surgical site infection. Available at http://hcai.dh.gov.uk/files/2011/03/2011-03-14-HII-Prevent-Surgical-Site-Infection-FINAL.pdf. Date accessed: 12.04.11

Latest Issues

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026

AfPP Annual National Conference 2026

Wyboston Lakes Resort
7th – 8th August 2026

The Annual Operating Theatres Show

Manchester (Etihad)
10th September 2026

AfPP Regional Conferences: London

Cavendish Conference Centre
12th September 2026

CSC Autumn Study Day 2026

Holiday Inn, Birmingham Airport - NEC by IHG
12th October 2026